Leading Pharma 401(K) Plan — Form 5500 plan (Leading Pharma, LLC)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Leading Pharma 401(K) Plan is a benefit plan reported by Leading Pharma, LLC under EIN 47-1297885 and plan number 001. The latest loaded filing year is 2023. The filing reports 221 participants and $4,957,143 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Leading Pharma, LLC
EIN
47-1297885
Plan number
001
Plan type
2
Location
Fairfield, NJ
Latest filing year
2023
Participants
221
End-of-year plan assets
$4,957,143

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
2023221H, C20241002135307NAL0004845923001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$4,957,143
Total liabilities (EOY)
$0
Net assets (EOY)
$4,957,143
Net assets (BOY)
$3,755,977

Income & contributions

Employer contributions
$310,836
Participant contributions
$616,667
Total contributions
$978,955
Total income / additions
$1,639,871

Expenses & distributions

Benefits paid
$408,501
Administrative expenses
$30,204
Total expenses
$438,705
Net increase / (decrease)
$1,201,166

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Nationwide Life Insurance CoINVESTMENTS RECORDKEEPER$63,816$5,7382023
Securian Financial Services InINVESTMENTS$0$17,7282023
Stadion Money Management, LLCINVESTMENTS$14,918not reported in the loaded dataset2023
Cetera Advisor Networks LLCINVESTMENTS$0$6,6342023
Iron-Co-Fid-ComprehensiveINVESTMENTS$5,438not reported in the loaded dataset2023
Planned Financial ProgramsTHIRD PARTY ADMINISTRATO$5,045not reported in the loaded dataset2023

Related Form 5500 pages